The article discusses Sam Altman, the CEO of OpenAI, and his various interests and investments outside of his work at OpenAI. Some of these interests include:
* Nuclear energy: Altman has called past bans on nuclear energy over safety concerns "incredibly dumb" and has financially backed the nuclear energy startup Helion.
* Longevity pills: Altman is a proponent of longevity technology and has invested in Retro Biosciences, a company aiming to launch clinical trials for antiageing effects on the brain.
* Brain scans: Altman's venture Tools for Humanity has been working on scanning people's eyeballs using a biometric collection device called the "orb" to verify human identity online.
* Neural interfaces: Altman thinks neural interfaces are cool ideas to explore and has expressed interest in being able to think something and have ChatGPT respond to it.
These interests suggest that Altman is interested in exploring new technologies that could potentially benefit humanity, but also raises questions about the ethics of using these technologies for various purposes.
* Nuclear energy: Altman has called past bans on nuclear energy over safety concerns "incredibly dumb" and has financially backed the nuclear energy startup Helion.
* Longevity pills: Altman is a proponent of longevity technology and has invested in Retro Biosciences, a company aiming to launch clinical trials for antiageing effects on the brain.
* Brain scans: Altman's venture Tools for Humanity has been working on scanning people's eyeballs using a biometric collection device called the "orb" to verify human identity online.
* Neural interfaces: Altman thinks neural interfaces are cool ideas to explore and has expressed interest in being able to think something and have ChatGPT respond to it.
These interests suggest that Altman is interested in exploring new technologies that could potentially benefit humanity, but also raises questions about the ethics of using these technologies for various purposes.